watch
Heron Therapeutics, Inc.

Heron Therapeutics, Inc.

Sector: Pharmaceutical Preparations Region: CA, United States


: | Nasdaq: HRTX


Similar to: Skystar Bio-Pharmaceutical Co., Guerbet SA, Sanofi

Heron Therapeutics, Inc. is a pharmaceutical company. It designs and commercializes of polymer technologies for pharmaceutical and other applications. The company develops products using its proprietary Biochronomer polymer based drug delivery technology. Its primary focus is on its product APF530, for the prevention of chemotherapy induced nausea and vomiting. The company has additional clinical and preclinical-stage programs in the area of pain management, all of which utilize its bioerodible, injectable and implantable delivery systems. Its Biochronomer technology is applicable to a range of therapeutics areas, including prevention of nausea and vomiting, pain management, control of inflammation and treatment of ophthalmic diseases. The company was founded in February 1983 and is headquartered in Redwood City, CA

News & Analysis

You may also be interested in: